CDNA News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

CD

Mkt Cap

$3.31B

Volume

1.23M

Next Earnings

October 29th

Loading chart

CD

CDNACareDx, Inc.

CDNA

Pay with—

Available Balance0.00

CD

Mkt Cap

$3.31B

Volume

1.23M

Next Earnings

October 29th

Chart Financials Earnings News About Insider Filings

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGRThe global immunogenomics market is projected to grow from USD 6.32 billion in 2025 to USD 9.82 billion by 2033, expanding at a CAGR of 5.97%. Growth is driven by advancements in next-generation sequencing technologies, increasing demand for personalized medicine, and rising prevalence of immune-related disorders. Key applications include oncology, infectious disease research, vaccine development, and autoimmune disorder studies, with adoption across hospitals, diagnostic laboratories, pharmaceutical companies, and academic institutions.GlobeNewswire Inc. · Oct 5, 2026

Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 PicksConsumer confidence fell 6.7% to 81.9 in September 2026, hitting its lowest level since April 2014, driven by concerns about labor market conditions and Middle East geopolitical tensions. The Federal Reserve hiked interest rates by 25 basis points and hinted at further increases. In response, four defensive stocks from healthcare and consumer staples sectors are recommended: Bausch Health Companies, CareDx, Dole, and The Chefs' Warehouse.Zacks Investment Research · Sep 30, 2026

4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate HikeWith inflation remaining stubbornly high at 3.4% annually and a 90% probability of a Federal Reserve rate hike expected, the article recommends four defensive healthcare stocks: Amgen, Bausch Health, CareDx, and Centene. CareDx and Centene are expected to deliver over 100% earnings growth this year, while all four stocks have seen improved earnings estimates over the past 60 days.Zacks Investment Research · Sep 14, 2026

Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive PicksRising oil prices amid escalating Middle East tensions between the US and Iran are driving market volatility and inflation concerns. The Federal Reserve is expected to hike interest rates next month. Investors are rotating toward defensive stocks in consumer staples and healthcare sectors.Zacks Investment Research · Sep 9, 2026

Why CareDx Stock Jumped TodayCareDx stock surged 14.72% after the precision medicine diagnostics company raised its full-year revenue and earnings forecasts. The company reported adjusted net income more than tripled to $20 million ($0.37 per share), significantly exceeding Wall Street estimates of $0.23 per share. Growth was driven by increased demand for non-invasive transplant monitoring tests, favorable reimbursement dynamics, and CMS coverage affirmation for kidney, heart, and lung transplant surveillance testing.The Motley Fool · Jul 31, 2026

CareDx Sharpens Focus On Core Testing ServicesCareDx agreed to sell its Lab Products business to EuroBio Scientific for $170 million in cash, allowing the company to focus on its higher-growth Testing Services and Patient and Digital Solutions segments. The company reported strong preliminary Q1 2026 results with 39% year-over-year revenue growth, with Testing Services up 48% and Patient and Digital Solutions up 33%. CareDx stock surged 28.54% on the announcement.Benzinga · Apr 16, 2026

CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026CareDx CEO John Walter Hanna Jr. sold 19,480 shares on January 21-22, 2026, totaling approximately $412,200 at an average price of $21.16 per share through a pre-planned Rule 10b5-1 trading plan. The sale reduced his direct holdings by 3.16%, leaving him with 597,405 shares. The article notes this shouldn't concern investors, as the company reported strong Q4 2025 preliminary results with $108 million in revenue (25% YoY growth) and expects continued growth in 2026 from its testing solutions.The Motley Fool · Feb 1, 2026

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. ShareholdersJohnson Fistel, a law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. for potential breaches of fiduciary duties and violations of federal securities laws. The investigation is related to CareDx's issuance of false and misleading public statements regarding its compliance with healthcare laws and revenue growth, which led to a significant drop in the company's stock price.GlobeNewswire Inc. · May 22, 2025

ALERTA PARA LOS ACCIONISTAS: Morris Kandinov investiga a CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., y Tax Free Fund for Puerto Rico Residents, Inc.; se anima a los accionistas a ponerse en contacto con la firmaThe law firm Morris Kandinov is investigating several companies, including CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc., for potential breaches of fiduciary duties and other legal violations on behalf of shareholders.GlobeNewswire Inc. · Sep 24, 2024

SHAREHOLDER ALERT: Morris Kandinov Investigating CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc.; Shareholders are Encouraged to Contact the FirmMorris Kandinov, a national law firm, is investigating potential breaches of fiduciary duties and other legal violations by CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc. Shareholders are encouraged to contact the firm to learn more about their rights.GlobeNewswire Inc. · Sep 24, 2024

to start trading

CD

CDNACareDx, Inc.

CDNA

Pay with—

Available Balance0.00

Your PositionYou don't own any CDNA yet.

Related Tickers

Earnings